Condition

Hepatocellulcar Carcinoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Intensified versus conversion therapy for advanced liver cancer after first-line bevacizumab plus sintilimab fails

  This study tests whether adding lenvatinib or switching to regorafenib plus a PD-1 blocker works better and is safe for adults with advanced hepatocellular carcinoma whose cancer progressed after first-line bevacizumab plus sintilimab.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07501351

• Dalpiciclib plus camrelizumab for advanced liver cancer after prior immunotherapy

  This trial will test whether combining dalpiciclib with camrelizumab can control tumors in people with unresectable hepatocellular carcinoma whose cancer progressed after prior immune checkpoint inhibitor treatment.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07238881

Related topics

Quick answers

How many Hepatocellulcar Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →